Diuretic Resistance

被引:96
作者
Hoorn, Ewout J. [1 ]
Ellison, David H. [2 ,3 ]
机构
[1] Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[2] Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA
[3] VA Portland Hlth Care Syst, Portland, OR USA
基金
美国国家卫生研究院;
关键词
Diuretic resistance; pathophysiology; edema; oral loop diuretic; nephrotic syndrome; triamterene; eNaC; epithelial Na+ channel; SCNN1B; proteinuria; kidney disease; cryoglobulinemic membranoproliferative glomerulonephritis; hepatitis C virus; RENIN-ANGIOTENSIN SYSTEM; CHRONIC RENAL-DISEASE; NEPHROTIC SYNDROME; HEART-FAILURE; FUROSEMIDE THERAPY; SODIUM RETENTION; KIDNEY-DISEASE; PLASMIN; HYPERTENSION; ALDOSTERONE;
D O I
10.1053/j.ajkd.2016.08.027
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diuretic resistance is defined as a failure to achieve the therapeutically desired reduction in edema despite a full dose of diuretic. The causes of diuretic resistance include poor adherence to drug therapy or dietary sodium restriction, pharmacokinetic issues, and compensatory increases in sodium reabsorption in nephron sites that are not blocked by the diuretic. To illustrate the pathophysiology and management of diuretic resistance, we describe a patient with nephrotic syndrome. This patient presented with generalized pitting edema and weight gain despite the use of oral loop diuretics. Nephrotic syndrome may cause mucosal edema of the intestine, limiting the absorption of diuretics. In addition, the patient's kidney function had deteriorated, impairing the tubular secretion of diuretics. He was admitted for intravenous loop diuretic treatment. However, this was ineffective, likely due to compensatory sodium reabsorption by other tubular segments. The combination of loop diuretics with triamterene, a blocker of the epithelial sodium channel, effectively reduced body weight and edema. Recent data suggest that plasmin in nephrotic urine can activate the epithelial sodium channel, potentially contributing to the diuretic resistance in this patient. This case is used to illustrate and review the mechanisms of, and possible interventions for, diuretic resistance. (C) 2016 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 49 条
[1]  
Abdallah JG, 2001, J AM SOC NEPHROL, V12, P1335, DOI 10.1681/ASN.V1271335
[2]  
Agarwal R, 2000, J AM SOC NEPHROL, V11, P1100, DOI 10.1681/ASN.V1161100
[3]   Chlorthalidone for Poorly Controlled Hypertension in Chronic Kidney Disease: An Interventional Pilot Study [J].
Agarwal, Rajiv ;
Sinha, Arjun D. ;
Pappas, Maria K. ;
Amrnous, Farah .
AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (02) :171-182
[4]   Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells [J].
Andersen, Henrik ;
Friis, Ulla G. ;
Hansen, Pernille B. L. ;
Svenningsen, Per ;
Henriksen, Jan Erik ;
Jensen, Boye L. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (05) :781-789
[5]   Over- or underfill: not all nephrotic states are created equal [J].
Bockenhauer, Detlef .
PEDIATRIC NEPHROLOGY, 2013, 28 (08) :1153-1156
[6]  
Brady HR, 1999, THERAPY NEPHROLOGY H, P672
[7]   Update in Diuretic Therapy: Clinical Pharmacology [J].
Brater, D. Craig .
SEMINARS IN NEPHROLOGY, 2011, 31 (06) :483-494
[8]   Diuretic therapy [J].
Brater, DC .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) :387-395
[9]   BUMETANIDE AND FUROSEMIDE [J].
BRATER, DC ;
CHENNAVASIN, P ;
DAY, B ;
BURDETTE, A ;
ANDERSON, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (02) :207-213
[10]   SODIUM RETENTION IN NEPHROTIC SYNDROME IS DUE TO AN INTRARENAL DEFECT - EVIDENCE FROM STEROID-INDUCED REMISSION [J].
BROWN, EA ;
MARKANDU, N ;
SAGNELLA, GA ;
JONES, BE ;
MACGREGOR, GA .
NEPHRON, 1985, 39 (04) :290-295